In addition, it has been reported that the overexpression of EZH2 promotes ASCL1 expression by repressing the transforming growth factor-β (TGFβ)–SMAD pathway through methylation, which in turn results in SCLC progression. This evidence concerns the gene TGFB1 and small cell lung carcinoma.